Literature DB >> 11017135

Specific immunotherapy: one size does not fit all.

C P Genain, S S Zamvil.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11017135     DOI: 10.1038/80424

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

Review 1.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Authors:  Reinhard Hohlfeld; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

Review 2.  Multiple Sclerosis and T Lymphocytes: An Entangled Story.

Authors:  Laurine Legroux; Nathalie Arbour
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-07       Impact factor: 4.147

Review 3.  HMG-CoA reductase inhibitors as immunomodulators: potential use in transplant rejection.

Authors:  Liza J Raggatt; Nicola C Partridge
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.

Authors:  Olaf Stüve; Sawsan Youssef; Martin S Weber; Stefan Nessler; Hans-Christian von Büdingen; Bernhard Hemmer; Thomas Prod'homme; Raymond A Sobel; Lawrence Steinman; Scott S Zamvil
Journal:  J Clin Invest       Date:  2006-03-16       Impact factor: 14.808

5.  Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks?

Authors:  Slobodan Culina; Christian Boitard; Roberto Mallone
Journal:  Clin Dev Immunol       Date:  2011-05-14

Review 6.  Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans.

Authors:  Isaac T W Harley; Kristen Allison; R Hal Scofield
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.